Tissue sections were routinely blocked for 30 minutes with the normal serum of the same species in which the secondary antibody was generated or with TNB solution (0.1M Tris-HCl, 0.15M NaCl, 0.5% blocking reagent) provided with the tyramide signal amplification kit (TSA kit, PerkinElmer, Waltham, MA; http://las.perkinelmer.com/ApplicationsSummary/Applications/Tyramide-Signal-Amplification.htm), a technique to enhance the visualization of immunolabeling. Tissue sections treated with the TSA kit were incubated with 0.3% hydrogen peroxide in methanol for 30 minutes to inactivate endogenous hydrogen peroxidase before applying the blocking reagent. The tissue sections were then incubated with the primary antibody overnight at room temperature, rinsed with TNT (0.1M Tris-HCl, 0.15 M NaCl, 0.3% Triton) buffer and then incubated for 1 hour in biotinylated goat anti-rat or anti-mouse immunoglobulin (secondary antibody, Jackson Immunoresearch, West Grove, PA), depending on the original species of the primary antibody. The TSA reagents then were applied, following the manufacturer’s instructions (peroxidase-conjugated strepavidin 1:200 for 30 minutes, and then biotin-conjugated tyramide 1:100 for 3 minutes). The immunoreactivity was visualized by incubation with strepavidin-conjugated Cy3 (Jackson ImmunoResearch) diluted 1:1800 for 25 minutes. To control for the specificity of secondary antibody, tissue sections were prepared by omitting the primary antibody. To control for the specificity of the primary antibody, tissue sections were prepared by substituting matched protein concentrations of normal serum of the species in which the primary antibody was generated. Tissue sections were covered in mounting in medium (Fluoromount-G; Southern Biotechnology Associates, Inc., Birmingham, AL) and observed by a fluorescence microscope (Nikon Microphot-SA; Nikon, Tokyo, Japan). Digital images were captured with a digital camera and imaging software (DXM1200 and ACT-1 version 2.20, respectively; both from Nikon).